LADENBURG THALMANN FINANCIAL SERVICES INC. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 189 filers reported holding REPLIGEN CORP in Q1 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2019$480,000
+20.0%
5,188
-0.7%
0.00%0.0%
Q3 2019$400,000
-29.9%
5,226
-21.1%
0.00%
-25.0%
Q2 2019$571,000
+75.7%
6,627
+20.8%
0.00%
+100.0%
Q1 2019$325,000
+20.8%
5,488
+7.2%
0.00%0.0%
Q4 2018$269,000
-3.9%
5,120
+1.5%
0.00%0.0%
Q3 2018$280,000
+44.3%
5,045
-5.7%
0.00%0.0%
Q2 2018$194,0000.0%5,3500.0%0.00%0.0%
Q1 2018$194,0000.0%5,3500.0%0.00%0.0%
Q4 2017$194,000
-5.4%
5,3500.0%0.00%0.0%
Q3 2017$205,000
-8.1%
5,350
-0.6%
0.00%
-33.3%
Q2 2017$223,000
-9.7%
5,381
-23.2%
0.00%0.0%
Q1 2017$247,000
+15.4%
7,002
+1.1%
0.00%0.0%
Q4 2016$214,000
-6.6%
6,927
-8.6%
0.00%0.0%
Q3 2016$229,000
-7.3%
7,577
-16.0%
0.00%
-25.0%
Q2 2016$247,000
-0.4%
9,018
-2.7%
0.00%0.0%
Q1 2016$248,000
-4.6%
9,268
+0.6%
0.00%
-20.0%
Q4 2015$260,000
+10.6%
9,212
+9.5%
0.01%0.0%
Q3 2015$235,000
-36.1%
8,414
-5.7%
0.01%
-28.6%
Q2 2015$368,000
+54.0%
8,921
+13.3%
0.01%
+40.0%
Q1 2015$239,000
+61.5%
7,871
+5.4%
0.01%
+66.7%
Q4 2014$148,000
+2860.0%
7,471
+2656.8%
0.00%
Q3 2014$5,000
-16.7%
2710.0%0.00%
Q2 2014$6,000
+100.0%
271
+35.5%
0.00%
Q1 2014$3,0000.0%2000.0%0.00%
Q4 2013$3,000
+50.0%
2000.0%0.00%
Q3 2013$2,0002000.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2018
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders